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 Introduction 
 Although the presence of hematopoietic stem cells 
(HSC) is well characterized in the bone marrow (BM), 
we have recently shown that the spleens of pigs, baboons 
and humans are also sources of early HSC [Dor et al., 
2004]. Although CD34 is often used as a marker of the 
earliest HSC, it is also known that, in the sequence of 
events associated with hematopoietic differentiation, 
porcine cells expressing c-kit (c-kit+) contain pluripo-
tent HSC as well [Le Guern et al., 2003]. Through the 
use of the cobblestone area-forming cell (CAFC) assay, 
an assay that defi nes the presence of early HSC [Ploe-
macher et al., 1989; Breems et al., 1994], we document-
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 Abstract 
 The adult spleen is a source of early hematopoietic stem 
cells (HSC). We therefore studied whether culturing 
spleen or bone marrow (BM) HSC in medium containing 
5-azacytidine could induce a cardiac phenotype. c-kit en-
richment and depletion of adult pig spleen and BM 
mononuclear cells were obtained by magnetic bead sep-
aration using biotinylated pig stem cell factor (c-kit li-
gand). Cells were incubated with 5-azacytidine for 24 h 
and refreshed with 5-azacytidine-free medium every
48 h. Western blot was used to detect cardiac troponin 
and myosin heavy chains. Although 5-azacytidine treat-
ment led to the formation of ball-like cell clusters in both 
c-kit-enriched populations, these clusters showed no 
rhythmic contractions (beating), as observed by others. 
Furthermore, neither cardiac troponin nor myosin was 
detected in cells derived from either source. Our meth-
odology and treatment with 5-azacytidine did not induce 
cardiac gene expression in porcine HSC derived from 
either pig spleen or BM. 
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Abbreviations used in this paper
BM Bone marrow
CAFC Cobblestone area-forming cell
HBSS Hanks balanced salt solution
HSC Hematopoietic stem cell
MACS Magnetic cell separation
MSC Bone marrow stromal cell
SCF Stem cell factor
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ed an equal frequency of these earliest stem cells in BM 
and spleen [Dor et al., 2004]. The question was then 
raised whether these c-kit+ stem cells might refl ect an 
early pluripotent state that could be directed away from 
hematopoietic fate. 
 Recent work at understanding the repair of infarcted 
myocardial tissue and the ability of fetal myocardial cells 
to potentially repair cardiac tissue has generated interest 
in this fi eld as a potential therapeutic option [Leor et al., 
1996]. At the same time, ethical ramifi cations and techni-
cal problems of fetal tissue acquisition have generated 
great interest in adult stem cell populations and the abil-
ity of these cells to dedifferentiate and be directed toward 
other fates [Friedenstein et al., 1987; Ashton et al., 1980; 
Bennett et al., 1991; Rickard et al., 1994; Ferrari et al., 
1998]. Along these lines, the ability of 5-azacytidine, a 
cytosine analog, to induce altered gene expression and in 
vitro  cellular rhythmic contractions, associated with a 
cardiac phenotype, has been well documented [Constan-
tinides et al., 1977; Constantinides et al., 1978; Taylor 
and Jones, 1979; Fukuda, 2001]. Fukuda [2001] has dem-
onstrated that regenerative cardiomyocytes can be gener-
ated in the rat from BM stromal cells (MSC) using 5-aza-
cytidine, and Tomita et al. [2002] have demonstrated that 
porcine heart function improved following the infusion 
of 5-azacytidine-treated MSC into infarcted myocardi-
um.  
 In view of the work of Rangappa et al. [2003], which 
demonstrated the ability of adipose-derived rat mesen-
chymal stem cells to differentiate towards cardiac fate, a 
similar approach was applied to the c-kit-expressing HSC 
from the spleen and BM. The spleen, like the BM, is a 
hematopoietic tissue of mesodermal origin and, as such, 
may serve as a repository for stem cells that retain their 
plasticity. Recent work by Kodama et al. [2003], which 
showed that injected mouse splenocytes contribute to the 
regeneration of functional pancreatic islet cells, suggests 
that the transdifferentiation of splenic cells to an alternate 
phenotype may, in fact, be possible. 
 Based on the shared embryonic origins of the splenic 
and BM HSC, and further supported by their similar 
CAFC frequencies at 12 weeks of culture [Dor et al., 
2004], we attempted transformation of c-kit-expressing 
HSC from spleen and BM cells toward cardiac fate by an 
approach that has been reported to be successful by oth-
ers working with mesenchymal stem cells. 
 Materials and Methods 
 Animals 
 Four naive pigs were obtained from the Massachusetts General 
Hospital herd of partially inbred major histocompatibility com-
plex-defi ned miniature swine (aged 3–5 months), whose character-
istics have been described in detail previously [Sachs, 1992]. All 
procedures were in accordance with the  Principles of Laboratory 
Animal Care  formulated by the National Society for Medical Re-
search and the  Guide for the Care and Use of Laboratory Animals 
produced by the Institute of Laboratory Animal Resources and 
published by the National Institutes of Health (NIH publication 
No. 86–23, revised 1996). 
 Primary Culture of Porcine c-kit Cells 
 Spleen and sternal BM samples were obtained in a sterile fash-
ion from adult pigs immediately following the administration of an 
overdose of pentobarbital to induce euthanasia. The samples were 
washed in Hanks balanced salt solution (HBSS; Gibco, Grand Is-
land, N.Y., USA) and minced in a dish of RPMI 1640 culture me-
dium (Mediatech, Herndon, Va., USA). The resulting suspension 
was passed through a 40-micron fi lter (BD Biosciences, San Jose, 
Calif., USA), diluted 1:  1 with HBSS, and mononuclear cells iso-
lated using a gradient of lymphocyte separation medium (ICN Bio-
medicals, Aurora, Ohio, USA). The buffy coats were harvested and 
residual erythrocytes lysed using ACK lysing buffer (Cambrex Bio 
Science, Walkersville, Md., USA). The cells were resuspended in 
culture medium consisting of RPMI 1640, 15% fetal bovine serum, 
penicillin (1 U/ml), streptomycin (1 mg/ml), gentamicin (0.05 mg/
ml), amphotericin B (0.34   g/ml) (all from Gibco), Hepes buffer 
(10 m M; Mediatech) and glutamine (2 m M; Gibco). The cells were 
incubated with 1:  40 porcine biotinylated recombinant porcine 
stem cell factor (c-kit ligand) (BioTransplant, Charlestown, Mass., 
USA) [Le Guern et al., 2003], then with magnetic cell separation 
(MACS) anti-biotin magnetic microbeads (MiltenyiBiotec, Au-
burn, Calif., USA), and separated over MACS LS columns (Mil-
tenyiBiotec) with the negative fraction being retained for use in the 
c-kit-depleted (c-kit–) cultures. The c-kit+ cells were then eluted for 
use as HSC. Cells (1  ! 10 6 ) were removed from each population 
for fl uorescence-activated cell sorting analysis to evaluate purifi ca-
tion of the different populations. Both the c-kit+ and c-kit– cell 
populations from the spleen and BM were counted and separately 
seeded onto 25-cm 2  fl asks at a concentration of 1  ! 10 6  cells/ml in 
the same culture medium as above. At 24 h, the cells were trypsin-
ized (0.25% trypsin with EDTA; Mediatech) and resuspended in 
the above culture medium.  
 Treatment with 5-Azacytidine 
 Half of the cells from both c-kit+ and c-kit– cultures were trans-
ferred from the culture fl asks into 6-well plates in culture medium 
(as described above) with the addition of 5-azacytidine (Sigma-Al-
drich, St. Louis, Mo., USA) at a concentration of 9   M. This was 
the same concentration used in previous experiments in which a 
cardiac phenotype was observed. The other half was cultured in the 
same manner, in the absence of 5-azacytidine. After 24 h incuba-
tion with 5-azacytidine, 40% of the medium was removed from 
each well and replaced with fresh culture medium without 5-aza-
cytidine. The medium (40%) was again removed and replaced after 
36 and 48 h in order to titrate down the concentration of 5-aza-
cytidine as quickly as possible. Culture medium was thereafter 
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changed every 48 h. The cells were observed under an inverted light 
microscope at several time points over 5 weeks. 
 Phenotypic Assessment of Cell Cultures by Flow Cytometry 
 Cell suspensions for fl ow cytometry from the BM and spleen 
were resuspended in fl ow cytometry buffer, consisting of HBSS, 
0.1% BSA and 0.4% sodium azide (diluted 1:  1:1). Pig immuno-
globulin (5   g/10 6  cells) was added to prevent nonspecifi c binding. 
Cells were labeled with biotinylated recombinant porcine stem cell 
factor; biotinylated 12.2.2. (IgM) and fl uorescein isothiocyanate 
36.7.5 (IgG2a) were used as negative isotype-matched controls.  
 Western Blot and Visualization 
 After 5 weeks in culture, cells were removed from the bottom of 
the plates using 0.25% trypsin with EDTA and lysed at a concentra-
tion of 100   l/10 6  cells using a solubilization buffer, consisting of 
100 m M NaCl, 1.0% SDS, 50 m M tetraethylammonium chloride 
(pH 7.4), 1 m M DTT, 1 m M PMSF and Protease Inhibitor Cocktail 
for use with mammalian cell and tissue extracts 1:  1,000 (Sigma-
Aldrich). The resulting lysates were loaded under reducing condi-
tions onto SDS-PAGE gels (7.5 and 12.5% acrylamide for myosin 
and troponin staining, respectively). The proteins were then trans-
ferred to nitrocellulose membrane (Hybond C, Amersham Biosci-
ences, Piscataway, N.J., USA) and stained with Ponceau Red to 
assess protein transfer. The nitrocellulose was incubated in blocking 
buffer (PBS with 10% fetal bovine serum and 0.1% Tween) over-
night, washed and incubated for 1 h with either mouse anti-myosin 
heavy chain (with known pig reactivity, 0.2   g/ml) (Biodesign In-
ternational, Saco, Me., USA) or anti-troponin I (with known pig 
reactivity, 0.2   g/ml) (Novus Biologicals, Littleton, Colo., USA) 
monoclonal antibodies diluted in the same manner. The mem-
branes were washed in blocking buffer and incubated with horserad-
ish peroxidase-conjugated anti-mouse IgG (1:  25,000; Southern Bio-
technology Associates, Birmingham, Ala., USA). The SuperSignal 
West Pico chemiluminscent substrate kit (Pierce Biotechnology, 
Rockford, Ill., USA) was used to develop the blots. 
 Results 
 c-kit Purity by MACS Cell Separation 
 The isolation of c-kit+ populations from the BM was 
substantially more effi cient than that from the spleen tis-
sue ( table 1 ). Following cell separation, in the BM, there 
was a signifi cant difference in mean c-kit expression be-
tween the populations: 66.01% ( 8 14.67 SD) c-kit+ cells 
in the enriched population and 3.31% ( 8 1.76 SD) in the 
depleted population (p = 0.01). In the spleen, the separa-
tion came close to, but did not achieve, statistical signifi -
cance; enriched cultures contained a mean of 19.98%
( 8 7.07 SD) c-kit+ cells, and depleted samples contained 
3.44% ( 8 1.06 SD) c-kit+ cells (p = 0.05). When BM and 
spleen were compared, there was no statistical difference 
between the respective c-kit-enriched populations (p = 
0.07) or the respective c-kit-depleted populations (p = 
0.93). 
 Growth and Morphology of Cultures prior to
5-Azacytidine Treatment 
 Following separation, there was a gross difference in 
the overall morphology of the cells from the two tissues. 
BM c-kit+ isolates had cells that were larger and well 
rounded compared with splenic c-kit+ isolates, where the 
cells were much smaller and had more variation in shape 
( fi g. 1 ). In the c-kit– cultures, the BM cells were somewhat 
smaller than the corresponding c-kit+ BM cells, but still 
remained well rounded. Morphologically, splenic c-kit– 
cultures were not as distinct from splenic c-kit+ cells as 
in the BM. Both splenic populations were of the same 
relative size and featured variation in cell morphology 
that included both smaller, well-rounded cells and other 
more spindle-shaped cells. 
 Effects of 5-Azacytidine Treatment 
 Bone Marrow 
 Regardless of exposure to 5-azacytidine, there were 
substantial morphological variations between the sam-
ples ( table 2 ). In only one of the three 5-azacytidine-ex-
posed, c-kit-enriched BM samples were multinucleated 
fusion bodies visualized, resembling those observed by 
Taylor and Jones [1979] or Rangappa et al. [2003]. In this 
single culture, at 1 week, there were several separate foci 
of fi broblast or triangle-like morphology. This growth 
continued through week 2, with the joining of separate 
Table 1. Enrichment of c-kit HSC in porcine BM and spleen
Tissue c-kit, %
unseparated enriched depleted
BM
Trial 11 20.38 81.84 5.34
Trial 2 7.36 52.88 2.34
Trial 3 8.06 63.31 2.28
Mean 11.93 66.01 3.32
SD 7.32 14.67 1.75
Spleen
Trial 1 4.99 12.1 2.77
Trial 21 4.49 25.79 2.89
Trial 3 8.79 22.04 4.67
Mean 6.09 19.98 3.44
SD 2.35 7.07 1.06
c-kit unseparated = c-kit+ cells prior to separation over column; 
c-kit enriched = c-kit+ cells in enriched cultures; c-kit-depleted = 
c-kit+ cells in depleted cultures.
1 Samples that showed multinucleate ball masses.
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fi broblastic foci and the presence of multinucleated mass-
es by day 23 ( fi g. 2 a). The masses continued to grow in 
size until day 29, when they assumed a constant size with-
out further change in morphology. These masses ranged 
from 1 to 9 per well and were only present in foci with 
high fi broblastic activity. At no point during the 5 weeks 
of culture was either rhythmic or nonrhythmic beating 
observed in any of the structures.  
 The other two 5-azacytidine-exposed, c-kit-enriched 
BM samples showed similar fi broblastic activity through 
week 2, but there was no subsequent evidence of multi-
nucleated masses. A growth pattern without multinucle-
ated masses was consistently observed in each of the
c-kit-depleted cultures exposed to 5-azacytidine in addi-
tion to both groups of cultures that were not exposed to 
5-azacytidine at any time ( fi g. 2 b). Growth in cultures not 
exposed to 5-azacytidine was relatively decreased, with 
some cultures showing foci of growth that did not join 
with neighboring colonies. 
 Spleen 
 In the spleen, there was considerably greater variation 
( table 2 ). Multinucleated cell masses similar to those seen 
in the BM were visualized in only one culture that was 
 enriched for c-kit and exposed to 5-azacytidine. The ob-
served changes followed a time course similar to that in 
the corresponding BM culture ( fi g. 2 c). However, of the 
other two c-kit-enriched samples exposed to 5-azacytidine, 
fi broblastic activity was present in only one. The other 
culture remained static with cells fi xed to the bottom of 
the well, but with no visible sign of cellular extensions ( fi g. 
2 d). This same growth was observed in the cultures that 
were exposed to 5-azacytidine and depleted of c-kit, as well 
as in each of the cultures that were neither exposed nor 
enriched. In the c-kit-depleted populations that were not 
exposed to 5-azacytidine, strong fi broblastic activity was 
present in only one sample, which displayed the same clus-
tered cell masses as in the c-kit-enriched population. 
 Western Blot Analysis 
 Analysis by SDS-PAGE did not detect the presence 
of either cardiac troponin I or cardiac myosin heavy 
chain in any of the cultures generated, regardless of ex-
posure to 5-azacytidine. In those single BM and spleen 
cultures that showed multinucleated cell masses, ex-
pression of these proteins was again negative. Control 
samples of freshly processed porcine cardiac tissue were 
used as positive controls for the myosin heavy chain 
and troponin antibodies; fresh splenic tissue was used 
as a negative control in each gel ( fi g. 3 ). Extended expo-
sures of each blot were done in order to detect low
Table 2. Relationship between exposure to 5-azacytidine and morphology
Source
of cells
c-kit 5-Aza-
cytidine
Morphology of cells
(3 samples in each group)
BM enriched + 1 with fusion bodies
2 with fi broblastic activity but no fusion bodies
depleted + 3 with fi broblastic activity but no fusion bodies
enriched – 3 with comparatively decreased fi broblastic activity but no fusion bodies
depleted – 3 with comparatively decreased fi broblastic activity but no fusion bodies
Spleen enriched + 1 with fusion bodies
1 with fi broblastic activity and no fusion bodies
1 stagnant with no growth
depleted + 3 stagnant with no growth
enriched – 3 stagnant with no growth
depleted – 1 with strong fi broblastic-like growth but no fusion bodies
2 stagnant with no growth
 Fig. 1. BM and spleen c-kit-enriched cultures. One day after sepa-
ration over a magnetic column, BM c-kit-enriched cultures show 
larger and more rounded cells compared with spleen c-kit-enriched 
cultures.  a 14!;  b 14!. 
Fig. 2. BM and spleen c-kit-enriched populations showed various 
morphologies at day 21 following exposure to 5-azacytidine.  a BM 
culture showing a multinucleate fusion body.  b BM culture show-
ing fi broblastic growth, but no fusion bodies.  c Spleen culture show-
ing a multinucleate fusion body similar to that in  a .  d Spleen culture 
showing stagnation, with no growth or fi broblastic activity.  a 7!; 
 b 14!;  c 14!;  d 14!. 
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level expression of either myosin or troponin, but no 
signals were observed in any of the samples (data not 
shown). 
 Discussion 
 The ability of 5-azacytidine to induce novel gene ex-
pression has been documented by several different groups 
over the last few decades [Constantinides et al., 1977; 
Constantinides et al., 1978; Taylor and Jones, 1979; Fu-
kuda, 2001; Tomita et al., 2002; Rangappa et al., 2003]. 
Although Constantinides et al. [1977] were the fi rst to de-
scribe the appearance of multinucleated striated muscle 
cells in non-myeloblast precursors following 5-azacytidine 
treatment, it was Makino et al. [1999] who fi rst described 
the appearance of cardiomyocytes from immortalized 
MSC. Because it was necessary for cell lines to be immor-
talized for this conversion, any clinical utility of this meth-
odology remained questionable. However, soon after this, 
Tomita et al. [1999] reported that MSC in a primary cul-
ture were also capable of achieving this phenotype, and 
Rangappa et al. [2003] have recently reported that mes-
enchymal stem cells derived from fatty tissue in rats as-
sume a rhythmic beat consistent with cardiac phenotype 
following exposure to 5-azacytidine. However, there is 
some confl ict in the literature, as Liu et al. [2003] have 
reported an inability to reproduce these results in rat pri-
mary MSC cultures. Their work suggested that, unless the 
cell line was immortalized, a cardiac phenotype was not 
achievable. The present study was an attempt to add fur-
ther experience by assessing the utility of 5-azacytidine to 
infl uence the fate of porcine pluripotent HSC. 
 Based on our previous work, it was known that a small 
fraction of c-kit+ cells that were also CD9–, and there-
fore nonmobilized, were present in the spleen [Dor et al., 
2004]. The work of Le Guern et al. [2003], which showed 
that c-kit was a marker for HSC and that this cell popula-
tion displays early engraftment capacity, lead us to be-
lieve that these cells might be very early stem cells present 
in the spleen. Indeed, CAFC assays indicated that the 
earliest stem cells in the spleen were present at an equal 
frequency to those in the BM, raising the question of 
whether this population, or another splenic cell popula-
 Fig. 3. Absence of expression of troponin I or myosin in BM or spleen cultures on Western blot. BM and spleen 
stained for troponin ( a ,  b ); BM and spleen stained for myosin ( c ,  d ). 1 = Molecular marker; 2 = cardiomyocytes 
(control); 3 = BM c-kit enriched + 5-azacytidine, 4 = BM c-kit depleted + 5-azacytidine; 5 = spleen c-kit enriched, 
no 5-azacytidine; 6 = spleen c-kit depleted, no 5-azacytidine; 7 = homogenized spleen (control). Lanes 2 and 7 are 
positive and negative control, respectively.
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tion, may have the same potential as the mesenchymal 
stem cells and MSC described above. It was a central 
premise to our study whether enrichment for c-kit would 
improve the conversion of HSC to cardiac phenotype, if 
this were at all achievable. Although CD34 is a widely 
used marker for HSC in rodents and humans, there is not 
yet a commercially available anti-CD34 antibody for 
pigs. However, c-kit+ expression is known to have a 
strong correlation with stem cell activity and can there-
fore be reliably used as a stem cell marker in pigs [Le 
Guern et al., 2003; Dor et al., 2004]. By using both BM 
and spleen as sources of HSC, it has been possible to com-
pare the results, not only between these two sources, but 
also between splenic HSC and the MSC described by oth-
ers [Makino et al., 1999; Tomita et al., 1999; Liu et al., 
2003; Rangappa et al., 2003]. If such an increase in effi -
cacy had been seen, there would have been some argu-
ment for including c-kit as a possible marker for increased 
plasticity and potential conversion to cardiomyocytes. If 
c-kit expression were unrelated to phenotype conversion, 
there would have been a similar frequency of cardiac con-
version regardless of the enrichment status, provided that 
the cells were still exposed to 5-azacytidine. If this were 
the case, it was hypothesized that separation over a mag-
netic column would not affect the results. However, it 
should be noted that we were unable to achieve the same 
effi cacy in separation in the spleen as in the BM, despite 
the same methodology. This may result from the fact that, 
although spleen cells express c-kit, they do not express
c-kit high  as do the HSC of the BM [Dor et al., 2004]. This 
distinction may be one cause for the difference in purity 
of the cells obtained from the MACS columns. Although 
the effect of this variation remains uncertain, we believed 
that it was more important to maintain an identical, stan-
dardized separation protocol for both tissues. Thus, we 
included any cells expressing c-kit, whether c-kit high  or
c-kit low , in the c-kit+ group, and only those cells failing to 
express any c-kit at all in the c-kit– group. 
 Our results were consistent with those observed by Liu 
et al. [2003]. Although we observed a fi broblastic growth 
pattern similar to Rangappa et al. [2003], our cultured 
cells not only failed to beat, they also failed to express 
cardiac-specifi c troponin and myosin proteins at any lev-
el. The gross appearance of the multinucleate structures 
in one BM and one spleen from separate animals was 
most consistent with the formation of chondrocyte struc-
tures fi rst described by Taylor and Jones [1979]. How-
ever, as noted by Chacko et al. [1969] and Benya et al. 
[1978], the chondrocyte phenotype in culture is quite un-
stable and degrades with subculture. As a result, it was 
impossible to better analyze the composition of these 
structures. We do not exclude the possibility that the mul-
tinucleate masses we observed may have been foci of cell 
types other than cardiac cells. In view of our interest in 
applying the successful approach of other scientists work-
ing with 5-azacytidine and cardiac transformation, our 
experiments focused only on determining the presence of 
cardiac-specifi c troponin and myosin. However, the in-
frequent and seemingly random appearance of the mul-
tinucleate structures in our work attests to the argument 
by Liu et al. [2003] that genetic reprogramming by 5-aza-
cytidine may be nonspecifi c. Because it is a cytosine ana-
logue and appears to work by altering gene methylation 
[Jones and Taylor, 1980], it is more feasible to hypothe-
size a sequence of random gene activation than specifi c 
cardiac gene potentiation.  
 The basis for the discrepancy between our results and 
those of some others is diffi cult to assess [Constantinides 
et al., 1977; Constantinides et al., 1978; Taylor  and Jones, 
1979; Fukuda, 2001; Tomita et al., 2002; Rangappa et al., 
2003]. Since we did not carry out a ‘control’ experiment 
in an attempt to confi rm that, following exposure to 5-
azacytidine, porcine MSC can differentiate into cardio-
myocytes, or compare porcine HSC with their murine 
counterparts, the negative result we obtained could be as-
sociated with technical discrepancies or failures. For ex-
ample, the particular culture conditions we employed 
may not have been appropriate for porcine cells. Further-
more, our lack of better ‘control’ experiments is explained 
by the considerably low cell yield associated with the pu-
rifi cation and separation procedures; it afforded us only 
enough cells to carry out the ‘experimental’ segment of 
our protocol. Increasing the number of experiments 
would not have addressed this problem, as the issue was 
one of low cell yield following separation and not neces-
sarily variation between the samples of each tissue exam-
ined. A fi nal possibility is that, although we were not able 
to confi rm troponin and myosin expression in these cells 
at the 5-week time point, other cardiac proteins, such as 
Nk2.5 or alpha-actinin, may have been present at other 
time points during the experiment. As the scope of our 
study was limited by the commercial availability of por-
cine markers for these proteins, we were not able to in-
vestigate for their presence. As this was an initial study 
into the ‘plasticity’ of splenic HSC, we restricted our 
Western blot analysis to those cardiac proteins described 
by others and did not attempt detection of proteins that 
may be expressed by bone, cartilage or endothelial cells. 
These limitations can only be resolved by further inves-
tigations, possibly on a larger scale.  
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 The goal of our work was not to defi nitively answer the 
question of HSC plasticity in a porcine model, but rather 
to stimulate new thinking with regard to an alternative 
source of adult stem cells for transdifferentiation studies, 
namely the adult spleen. One other important difference 
that may account for variability in results is the donor 
species. Although Tomita et al. [2002] assessed porcine 
myocardial function following infarction and the subse-
quent infusion of 5-azacytidine-treated MSC, the major-
ity of in vitro studies have been in rodent species. Pig BM 
and splenic cells may not have the same pluripotency or 
transforming capabilities as those in lower mammals. It 
is also possible that, in the pig and higher mammals, cul-
ture by the method we utilized may drive the cells into a 
state of senescence, and therefore, are less susceptible to 
the effects of 5-azacytidine. Additionally, if 5-azacytidine 
requires a certain state of cellular interaction, enrichment 
or depletion of c-kit+ stem cells may be detrimental to the 
intercellular contact or cytokine-mediated microenviron-
ment that may be necessary. The enrichment of c-kit+ 
cells by MACS may have resulted in the removal or de-
struction of critical cellular components through specifi c 
or nonspecifi c binding to the column; however, the lack 
of correlation between fi broblastic growth states and in-
dividual c-kit concentrations suggests that other mecha-
nisms may be at work. Finally, only one concentration of 
5-azacytidine (9   M ) was tested, based upon previous 
reports that this concentration was the most effective at 
inducing cardiac phenotype [Rangappa et al., 2003]. As 
our cells were plated at a higher density than that previ-
ously reported [Rangappa et al., 2003], the concentration 
of 5-azacytidine may not have been suffi cient. While the 
absence of any clear cardiomyocyte phenotype is consis-
tent with the failure to detect either myosin or troponin 
by Western blot, it is also possible that this technique may 
not have been sensitive enough to distinguish expression 
of these proteins by a small subpopulation of cells. 
 Our study does not preclude the ability of BM and 
splenic cells to be transformed towards cardiac pheno-
type. It does, however, suggest that our methodology for 
the enrichment or depletion of c-kit+ stem cells does not 
effi ciently affect this process. 
 Conclusions 
 Treatment with 5-azacytidine of cultures derived 
from the porcine BM and spleen led to an unpredictable 
pattern of growth. Regardless of exposure to 5-azacyti-
dine, fi broblastic activity was present to varying extent 
among separate populations of c-kit+ and c-kit– popula-
tions. Although there were some ball-like formations in 
both BM and spleen c-kit+ populations that were similar 
to those observed by others, these cell clusters showed 
no sign of in vitro beating. Furthermore, neither cardiac 
troponin nor myosin heavy chain were detected by West-
ern blot in cells derived from either source. These results 
suggest that, using the protocol we employed, MACS of 
c-kit+ stem cells and treatment with 5-azacytidine is not 
an effi cient means of inducing cardiac gene expression 
in porcine HSC derived from either BM or spleen. 
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